In attempt to develop a PET radiotracer designed to bind PHF tau, benzo[4,5]imidazole[1,2-a]pyrimidines fluorescent compounds were screened against PHF tau in AD brains yielded T726, which demonstrated selective binding to tau over Aβ plaques. The gene discussed is MAPT; the disease is Alzheimer disease.